Roger Yates

Pharmacokinetics and Tolerability of the Orally Active Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 in Healthy Volunteers

Helen Swaisland, Alison Laight, Lesley E. Stafford et al. · Clinical Pharmacokinetics · 2001 · 118 citations

Medicine, Healthy Volunteers, Skin Pharmacology +3

Preliminary Studies of the Pharmacokinetics and Tolerability of Zolmitriptan Nasal Spray in Healthy Volunteers

Roger Yates, K Nairn, Ruth Dixon et al. · The Journal of Clinical Pharmacology · 2002 · 49 citations · Full text

Distribution of Zolmitriptan into the CNS in Healthy Volunteers

Anders Wall, Matts K gedal, Mats Bergstr m et al. · Drugs in R&D · 2005 · 43 citations

Medicine, Healthy Volunteers, Neuropharmacology +6

Blood–Brain Barrier Penetration of Zolmitriptan—Modelling of Positron Emission Tomography Data

Mats Bergström, Roger Yates, Anders Wall et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2006 · 33 citations

Positron Emission Tomography, Medical Imaging, Pet-mri +9

Pharmacokinetics, Dose Proportionality, and Tolerability of Single and Repeat Doses of a Nasal Spray Formulation of Zolmitriptan in Healthy Volunteers

Roger Yates, K Nairn, Ruth Dixon et al. · The Journal of Clinical Pharmacology · 2002 · 30 citations